Related Experiment Video
Updated: Jul 15, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
MAP kinase signalling pathways in cancer.
1The Beatson Institute for Cancer Research, Bearsden, Glasgow, UK. a.dhillon@beatson.gla.ac.uk
Oncogene
|May 15, 2007
Summary
Cancer involves cell communication errors, particularly in mitogen-activated protein kinase (MAPK) pathways. While Ras-Raf mutations drive cancer, stress-activated pathways may inhibit it, impacting treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Cancer is fundamentally a disease of disrupted cellular communication.
- Mitogen-activated protein kinase (MAPK) pathways are frequently implicated in cancer development.
- Aberrations in these pathways are pleiotropic, affecting multiple cellular functions.
Purpose of the Study:
- To review recent findings and hypotheses on the role of MAPK pathways in cancer.
- To highlight specific MAPK pathway components frequently mutated in cancer.
- To explore the contrasting roles of different MAPK pathways in tumorigenesis.
Main Methods:
- Literature review of recent findings and hypotheses.
- Discussion of genetic mutations in key MAPK pathway components.
- Analysis of the functional roles of stress-activated versus growth-promoting MAPK pathways.
Main Results:
- Mutations in Ras and B-Raf within the extracellular signal-regulated kinase (ERK) pathway are common in cancer.
- Stress-activated pathways, including Jun N-terminal kinase (JNK) and p38, appear to counteract malignant transformation.
- The interplay between different MAPK pathways varies across tumor types.
Conclusions:
- MAPK pathway signaling is critical in cancer biology.
- Understanding the balance of MAPK pathway activity is crucial for predicting cancer outcomes.
- Differential MAPK pathway activity influences sensitivity to cancer drug therapies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...